2015
DOI: 10.17992/lbl.2015.06.32
|View full text |Cite
|
Sign up to set email alerts
|

Innflutt fersk matvæli og sýkingaráhætta fyrir menn

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 34 publications
0
1
0
Order By: Relevance
“…Several proteinases, including neutrophil elastase, cathepsin G and chymotrypsin can have inhibitory effects at PAR1 and PAR2 such that they cleave the exodomain of the receptor without inducing activation of Gαq-coupled calcium signalling, thereby preventing activation by activating proteinases but not by agonist peptides. Neutrophil elastase (NE) cleavage of PAR1 and PAR2 can however activate MAP kinase signaling by exposing a TL that is different from the one revealed by trypsin [1764] Endogenous agonists QRFP26 (QRFP) [343,999] Agonists LV-2186 [41], LV-2172 [1572] Selective antagonists compound 25e (pIC 50 7.3) [687,688] Labelled ligands [ 125 I]QRFP43 (human) (Agonist) [641,1164,2090], [ 125 I]26RFa (human) (Agonist) [260] Comments: The orphan receptor GPR83 (9NYM4) shows sequence similarities with the QRFP receptor, as well as with the NPFF1, NPFF2, and PrRP receptors. ).…”
Section: Proteinase-activated Receptorsmentioning
confidence: 99%
“…Several proteinases, including neutrophil elastase, cathepsin G and chymotrypsin can have inhibitory effects at PAR1 and PAR2 such that they cleave the exodomain of the receptor without inducing activation of Gαq-coupled calcium signalling, thereby preventing activation by activating proteinases but not by agonist peptides. Neutrophil elastase (NE) cleavage of PAR1 and PAR2 can however activate MAP kinase signaling by exposing a TL that is different from the one revealed by trypsin [1764] Endogenous agonists QRFP26 (QRFP) [343,999] Agonists LV-2186 [41], LV-2172 [1572] Selective antagonists compound 25e (pIC 50 7.3) [687,688] Labelled ligands [ 125 I]QRFP43 (human) (Agonist) [641,1164,2090], [ 125 I]26RFa (human) (Agonist) [260] Comments: The orphan receptor GPR83 (9NYM4) shows sequence similarities with the QRFP receptor, as well as with the NPFF1, NPFF2, and PrRP receptors. ).…”
Section: Proteinase-activated Receptorsmentioning
confidence: 99%